L. Sullivan

发表

Initial strategies for integrating buprenorphine into HIV care settings in the United States.

R. D. Bruce, L. Eldred, D. Fiellin, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Oral substitution treatment of injecting opioid users for prevention of HIV infection.

M. Farrell, R. Ali, L. Gowing, 2011, The Cochrane database of systematic reviews.

HIV Treatment Outcomes Among HIV-Infected, Opioid-Dependent Patients Receiving Buprenorphine/Naloxone Treatment within HIV Clinical Care Settings: Results From a Multisite Study

R. D. Bruce, F. Altice, P. Korthuis, 2011, Journal of acquired immune deficiency syndromes.

The impact of alcohol use on depressive symptoms in human immunodeficiency virus-infected patients.

D. Cheng, R. Saitz, J. Samet, 2008, Addiction.

Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.

M. Pantalon, P. O'Connor, R. Schottenfeld, 2006, The New England journal of medicine.

A meta-analysis of the efficacy of nonphysician brief interventions for unhealthy alcohol use: implications for the patient-centered medical home.

B. Turner, R. Braithwaite, D. Fiellin, 2011, The American journal on addictions.

Food Insecurity is Associated with Poor Virologic Response among HIV-Infected Patients Receiving Antiretroviral Medications

A. Justice, K. Mattocks, D. Leaf, 2011, Journal of General Internal Medicine.

Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone.

A. Justice, D. Fiellin, L. Sullivan, 2012, Alcoholism, clinical and experimental research.

Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative Study

Declan T. Barry, P. O'Connor, R. Schottenfeld, 2009, Journal of General Internal Medicine.

Counseling and Directly Observed Medication for Primary Care Buprenorphine Maintenance: A Pilot Study

Declan T. Barry, P. O'Connor, R. Schottenfeld, 2012, Journal of addiction medicine.

Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/Naloxone

F. Altice, P. O'Connor, R. Schottenfeld, 2011, Journal of acquired immune deficiency syndromes.

Patient Satisfaction with Primary Care Office-Based Buprenorphine/Naloxone Treatment

Declan T. Barry, M. Pantalon, P. O'Connor, 2007, Journal of General Internal Medicine.

Substance Abuse and HIV: Treatment Challenges

D. Fiellin, L. Sullivan, Jeanette M. Tetrault, 2010 .

Substance use in patients with sexually transmitted infections: results from a national U.S. survey.

L. Niccolai, D. Fiellin, L. Sullivan, 2010, The American journal on addictions.

A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine.

Declan T. Barry, P. O'Connor, R. Schottenfeld, 2013, The American journal of medicine.

HIV/AIDS, Comorbidity, and Alcohol

A. Justice, D. Fiellin, L. Sullivan, 2010, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

Buprenorphine/naloxone Treatment in Primary Care is Associated with Decreased HIV Risk Behaviors

Declan T. Barry, P. O'Connor, D. Fiellin, 2008 .

Capsule switching and capsule replacement in vaccine- preventable bacterial diseases

S. Basu, S. Stancliff, Duncan Smith-rohrberg, 2007 .

The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence.

Declan T. Barry, P. O'Connor, R. Schottenfeld, 2010, The American journal on addictions.

Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years.

Declan T. Barry, M. Pantalon, P. O'Connor, 2008, The American journal on addictions.

Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users.

D. Metzger, D. Fiellin, P. Fudala, 2005, Addiction.

Primary Care Office-based Buprenorphine Treatment: Comparison of Heroin and Prescription Opioid Dependent Patients

Declan T. Barry, P. O'Connor, R. Schottenfeld, 2007, Journal of General Internal Medicine.

Substitution treatment of injecting opioid users for prevention of HIV infection.

M. Farrell, R. Ali, L. Gowing, 2004, The Cochrane database of systematic reviews.

The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?

P. O'Connor, R. Schottenfeld, D. Fiellin, 2005, Drug and alcohol dependence.

Factors Affecting Clinician Educator Encouragement of Routine HIV Testing Among Trainees

P. Korthuis, R. Cook, J. Cofrancesco, 2012, Journal of General Internal Medicine.

Update in Addiction Medicine for the Generalist

D. Alford, J. Arnsten, J. Samet, 2007, Journal of General Internal Medicine.

Gender and non-medical use of prescription opioids: results from a national US survey.

J. Concato, D. Fiellin, L. Sullivan, 2008, Addiction.

Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review.

L. Sullivan, E. McCance-Katz, S. Nallani, 2010, The American journal on addictions.

Update in HIV Medicine for the Generalist

A. Gifford, J. Cofrancesco, J. Sosman, 2009, Journal of General Internal Medicine.

Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates.

D. Fiellin, L. Sullivan, R. Desai, 2008, Drug and alcohol dependence.

Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence.

D. Fiellin, L. Sullivan, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis C and HIV infections: implications for clinical care in injection drug users.

D. Fiellin, L. Sullivan, 2004, The American journal on addictions.

Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection

M. Farrell, R. Ali, L. Gowing, 2006, Journal of General Internal Medicine.

Knowledge and Perceptions of HIV-Infected Patients Regarding HIV Transmission and Treatment in Ho Chi Minh City, Vietnam

N. Groce, L. Sullivan, D. Hoang, 2015, Asia-Pacific journal of public health.

Update in HIV Medicine for the Generalist

A. Gifford, J. Cofrancesco, J. Sosman, 2009 .

Effect of Incarceration History on Outcomes of Primary Care Office-based Buprenorphine/Naloxone

D. Fiellin, L. Sullivan, B. Moore, 2010, Journal of General Internal Medicine.

Provider and Practice Characteristics Associated with Use of Rapid HIV Testing by General Internists

S. Asch, P. Korthuis, R. Cook, 2011, Journal of General Internal Medicine.

Factors affecting willingness to provide buprenorphine treatment.

C. Cunningham, N. Sohler, J. Renner, 2009, Journal of substance abuse treatment.

Evaluation of a Combined Online and in Person Training in the Use of Buprenorphine

F. Levin, H. Kleber, D. Fiellin, 2006, Substance abuse.

Narrative Review: Buprenorphine for Opioid-Dependent Patients in Office Practice

D. Fiellin, L. Sullivan, 2008, Annals of Internal Medicine.

Opioids, chronic pain, and addiction in primary care.

Declan T. Barry, P. O'Connor, R. Schottenfeld, 2010, The journal of pain : official journal of the American Pain Society.

The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention.

S. Basu, F. Altice, S. Stancliff, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Training HIV Physicians to Prescribe Buprenorphine for Opioid Dependence

D. Fiellin, L. Sullivan, Jeanette M. Tetrault, 2006, Substance abuse.

HIV/AIDS, comorbidity, and alcohol: can we make a difference?

Amy C. Justice, David A. Fiellin, A. Justice, 2010 .

The prevalence and impact of alcohol problems in major depression: a systematic review.

P. O'Connor, D. Fiellin, L. Sullivan, 2005, The American journal of medicine.

A trial of integrated buprenorphine/naloxone and HIV clinical care.

Declan T. Barry, M. Pantalon, P. O'Connor, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors.

Declan T. Barry, M. Pantalon, P. O'Connor, 2008, Journal of substance abuse treatment.

The Impact of Cocaine Use on Outcomes in HIV-Infected Patients Receiving Buprenorphine/Naloxone

J. Mitty, P. O'Connor, R. Schottenfeld, 2011, Journal of acquired immune deficiency syndromes.

Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection.

M. Farrell, R. Ali, L. Gowing, 2006 .

Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection.

A. Justice, D. Fiellin, L. Sullivan, 2011, Drug and alcohol dependence.

General internists' beliefs, behaviors, and perceived barriers to routine HIV screening in primary care.

S. Asch, P. Korthuis, R. Cook, 2011, AIDS education and prevention : official publication of the International Society for AIDS Education.

Human Immunodeficiency Virus Testing Practices Among Buprenorphine-prescribing Physicians

R. Schottenfeld, D. Fiellin, L. Sullivan, 2012, Journal of addiction medicine.

Hepatic Safety and Lack of Antiretroviral Interactions With Buprenorphine/Naloxone in HIV-Infected Opioid-Dependent Patients

F. Altice, P. O'Connor, D. Fiellin, 2011, Journal of acquired immune deficiency syndromes.

Reply to Letter “Additional Explanation for Lack of Pharmacodynamic Interaction Between Atazanavir and Buprenorphine Reported by Vergara-Rodriquez et al”

F. Altice, D. Fiellin, L. Sullivan, 2011 .